TLR2 toll like receptor 2 [Homo sapiens (human)] - Gene

Summary

Official Symbol: TLR2provided by HGNC
Official Full Name: toll like receptor 2provided by HGNC
Primary source: HGNC:HGNC:11848
See related: Ensembl:ENSG00000137462 MIM:603028; AllianceGenome:HGNC:11848
Gene type: protein coding
RefSeq status: REVIEWED
Organism: Homo sapiens
Lineage: Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; Homo
Also known as: TIL4; CD282
Summary: The protein encoded by this gene is a member of the Toll-like receptor (TLR) family which plays a fundamental role in pathogen recognition and activation of innate immunity. TLRs are highly conserved from Drosophila to humans and share structural and functional similarities. This protein is a cell-surface protein that can form heterodimers with other TLR family members to recognize conserved molecules derived from microorganisms known as pathogen-associated molecular patterns (PAMPs). Activation of TLRs by PAMPs leads to an up-regulation of signaling pathways to modulate the host's inflammatory response. This gene is also thought to promote apoptosis in response to bacterial lipoproteins. This gene has been implicated in the pathogenesis of several autoimmune diseases. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]
Expression: Broad expression in appendix (RPKM 15.9), bone marrow (RPKM 12.6) and 18 other tissues See more
Orthologs: mouse all
NEW: Try the new Gene table
Try the new Transcript table

Genomic context

Location:: 4q31.3

Exon count:: 4

Annotation release	Status	Assembly	Chr	Location
RS_2023_10	current	GRCh38.p14 (GCF_000001405.40)	4	NC_000004.12 (153684280..153710637)
RS_2023_10	current	T2T-CHM13v2.0 (GCF_009914755.1)	4	NC_060928.1 (157008777..157030716)
105.20220307	previous assembly	GRCh37.p13 (GCF_000001405.25)	4	NC_000004.11 (154605432..154627412)

Chromosome 4 - NC_000004.12 Genomic Context describing neighboring genes

Genomic regions, transcripts, and products

Go to the top of the page Help

Go to reference sequence details

Genomic Sequence:

Go to nucleotide: Graphics FASTA GenBank

Expression

Go to the top of the page Help

See details

Project title: HPA RNA-seq normal tissues
Description: RNA-seq was performed of tissue samples from 95 human individuals representing 27 different tissues in order to determine tissue-specificity of all protein-coding genes
BioProject: PRJEB4337
Publication: PMID 24309898
Analysis date: Wed Apr 4 07:08:55 2018

Bibliography

Go to the top of the page Help

GeneRIFs: Gene References Into Functions

What's a GeneRIF?

Association between genetic variants of TLR2, TLR4, TLR9 and schizophrenia.
Title: Association between genetic variants of TLR2, TLR4, TLR9 and schizophrenia.
Expression of TLR2, IL-1beta, and IL-10 Genes as a Possible Factor of Successful or Pathological Aging in Nonagenarians.
Title: Expression of TLR2, IL-1β, and IL-10 Genes as a Possible Factor of Successful or Pathological Aging in Nonagenarians.
p53 suppresses the inflammatory response following respiratory syncytial virus infection by inhibiting TLR2.
Title: p53 suppresses the inflammatory response following respiratory syncytial virus infection by inhibiting TLR2.
Association between polymorphisms of TLR2-1-6 and bipolar disorder in a tunisian population.
Title: Association between polymorphisms of TLR2-1-6 and bipolar disorder in a tunisian population.
Human Toll-like receptor 2 genetic polymorphisms with tuberculosis susceptibility: A systematic review and meta-analysis.
Title: Human Toll-like receptor 2 genetic polymorphisms with tuberculosis susceptibility: A systematic review and meta-analysis.
Analysis of TLR2 in Primary Endocrine Resistant of Breast Cancer.
Title: Analysis of TLR2 in Primary Endocrine Resistant of Breast Cancer.
P. gingivalis-Induced TLR2 Interactome Analysis Reveals Association with PARP9.
Title: P. gingivalis-Induced TLR2 Interactome Analysis Reveals Association with PARP9.
miR-328-3p targets TLR2 to ameliorate oxygen-glucose deprivation injury and neutrophil extracellular trap formation in HUVECs via inhibition of the NF-kappaB signaling pathway.
Title: miR-328-3p targets TLR2 to ameliorate oxygen-glucose deprivation injury and neutrophil extracellular trap formation in HUVECs via inhibition of the NF-κB signaling pathway.
Age-Associated KLF9 Enhances the Inflammatory Response of Alveolar Macrophages Via Regulating TLR2 Expression.
Title: Age-Associated KLF9 Enhances the Inflammatory Response of Alveolar Macrophages Via Regulating TLR2 Expression.
Correlation of polymorphism in Toll-Like Receptor (TLR1 and TLR2) genes with susceptibility of pulmonary tuberculosis in Doda region of India.
Title: Correlation of polymorphism in Toll-Like Receptor (TLR1 and TLR2) genes with susceptibility of pulmonary tuberculosis in Doda region of India.

Submit: New GeneRIF Correction See all GeneRIFs (1406)

Phenotypes

Go to the top of the page Help

Find tests for this gene in the NIH Genetic Testing Registry (GTR)

Review eQTL and phenotype association data in this region using PheGenI

Associated conditions

Description	Tests
Colorectal cancer MedGen: C0346629 OMIM: 114500 GeneReviews: Lynch Syndrome	Compare labs
Leprosy, susceptibility to, 3 MedGen: C1968668 OMIM: 246300 GeneReviews: Not available	Compare labs
Mycobacterium tuberculosis, susceptibility to MedGen: C1834752 OMIM: 607948 GeneReviews: Not available	Compare labs

Variation

Go to the top of the page Help

See variants in ClinVar

See studies and variants in dbVar

See Variation Viewer (GRCh37.p13)

See Variation Viewer (GRCh38)

HIV-1 interactions

Go to the top of the page Help

Replication interactions

Interaction	Pubs
HIV-1 replication is enhanced by TLR2; when neutralized with anti-TLR2 antibody HIV-1 (BAL) proviral DNA is decreased relative to non-specific antibody in TZM-bl-2 cells	PubMed
HIV-1 infection is enhanced by TLR2 stimulation via Pam3CSK4 (a synthetic bacterial TLR2/1 ligand) in TZM-bl cells	PubMed
HIV-1 replication is enhanced by TLR2 stimulation or TNF treatment in Langerhans cells	PubMed

Protein interactions

Protein	Gene	Interaction	Pubs
Envelope surface glycoprotein gp120	env	The binding of soluble HIV-1 gp120 to TLR2 or TLR4 results in upregulation of the TNF-alpha and IL-8 production through NF-kappaB activation	PubMed
	env	Treatment of HIV-1 gp120 to astroglia displays significant increases in TLR2	PubMed
Envelope transmembrane glycoprotein gp41	env	Fully processed HIV-1 Env protein, once expressed on the cellular membrane, inhibits TLR2 activation	PubMed
	env	HIV-1 gp41 binds TLR2 (from TZM-bl-2 cell lysates)	PubMed
	env	siRNA knockdown of TLR2 in a HIV-1 gp41-exposed TLR2 transgene cell line, TZM-bl-2, decreases IL-8 production	PubMed
	env	Exposure of anti-TLR2 antibody-treated primary T cells to HIV-1 gp41 decreases IL-8 production	PubMed
	env	Exposure of TLR2 transgene cell lines (TZM-bl-2, HEK293-TLR2/1, HEK293-TLR2/6) to HIV-1 gp41 increases the production of IL-8	PubMed
	env	The HIV-1 gp41 transmembrane domain (TMD) inhibits the interaction between the TMDs of TLR2 and TLR6 in vitro	PubMed
	env	The transmembrane domain (TMD) of HIV-1 gp41 directly interacts with the TLR2 TMD within the membrane, partially through its GxxxG dimerization motif	PubMed
	env	The HIV-1 gp41 transmembrane domain inhibits TLR2-induced activation of ERK1/2, and secretion of TNF-alpha, MCP-1, and IL-6	PubMed
	env	The binding of soluble TLR2 to HIV-1 MA, CA, or gp41 inhibits the nuclear translocation of NFKB p65 subunit and downregulates IL-8 and CCR5 expression, leading to inhibition of HIV-1 infection in cells	PubMed
Nef	nef	HIV-1 Nef-mediated upregulation of TLR2 increases regulatory T cells (Tregs) and inhibits the proliferation of PBMCs	PubMed
	nef	HIV-1 Nef upregulates TLR2 expression via NF-kappaB activation in THP-1 cells	PubMed
Tat	tat	Treatment of HIV-1 Tat to astroglia displays significant increases in TLR2 expression	PubMed
capsid	gag	HIV-1 CA binds TLR2 (from TZM-bl-2 cell lysates)	PubMed
	gag	Exposure of the TLR2 transgene cell line, HEK293-TLR2/6, to HIV-1 CA (p24) increases the production of IL-8 BUT NOT in the TLR2 transgene cell lines, TZM-bl-2 and HEK293-TLR2/1	PubMed
	gag	Exposure of anti-TLR2 antibody-treated primary T cells to HIV-1 CA (p24) decreases IL-8 production	PubMed
	gag	The binding of soluble TLR2 to HIV-1 MA, CA, or gp41 inhibits the nuclear translocation of NFKB p65 subunit and downregulates IL-8 and CCR5 expression, leading to inhibition of HIV-1 infection in cells	PubMed
matrix	gag	HIV-1 MA (p17) binds TLR2 (from TZM-bl-2 cell lysates)	PubMed
	gag	siRNA knockdown of TLR2 in a HIV-1 MA (p17)-exposed TLR2 transgene cell line, TZM-bl-2, decreases IL-8 production	PubMed
	gag	Exposure of anti-TLR2 antibody-treated primary T cells to HIV-1 MA (p17) decreases IL-8 production	PubMed
	gag	Exposure of TLR2 transgene cell lines (TZM-bl-2, HEK293-TLR2/1, HEK293-TLR2/6) to HIV-1 MA (p17) increases the production of IL-8	PubMed
	gag	The binding of soluble TLR2 to HIV-1 MA, CA, or gp41 inhibits the nuclear translocation of NFKB p65 subunit and downregulates IL-8 and CCR5 expression, leading to inhibition of HIV-1 infection in cells	PubMed

Go to the HIV-1, Human Interaction Database

Interactions

Go to the top of the page Help

Products	Interactant	Other Gene	Complex	Source	Pubs	Description

General gene information

Go to the top of the page Help

Markers

PMC98129P1 (e-PCR)
- UniSTS:273665

PMC98226P1 (e-PCR)
- UniSTS:273667

PMC98510P1 (e-PCR)
- UniSTS:273671

PMC201071P1 (e-PCR)
- UniSTS:271880

D4S660 (e-PCR)
- UniSTS:95274

D4S841 (e-PCR)
- UniSTS:32812

TLR2 (e-PCR)
- UniSTS:503343

D4S575 (e-PCR)
- UniSTS:35904

G34296 (e-PCR)
- UniSTS:1092

SHGC4-1535 (e-PCR)
- UniSTS:51781

TLR2_1084.2 (e-PCR)
- UniSTS:466509

SHGC-33147 (e-PCR)
- UniSTS:62605

PMC37511P1 (e-PCR)
- UniSTS:273305

TLR2 (e-PCR)
- UniSTS:277943

AF368419 (e-PCR)
- UniSTS:277943

PMC55404P2 (e-PCR)
- UniSTS:273341

PMC128073P3 (e-PCR)
- UniSTS:270565

PMC97725P1 (e-PCR)
- UniSTS:273658

Gene Ontology Provided by GOA

Function	Evidence Code	Pubs
enables NAD+ nucleotidase, cyclic ADP-ribose generating	IEA Inferred from Electronic Annotation more info
enables Toll-like receptor binding	IPI Inferred from Physical Interaction more info	PubMed
enables amyloid-beta binding	IDA Inferred from Direct Assay more info	PubMed
enables amyloid-beta binding	ISS Inferred from Sequence or Structural Similarity more info
enables identical protein binding	IPI Inferred from Physical Interaction more info	PubMed
enables lipopolysaccharide binding	IDA Inferred from Direct Assay more info	PubMed
enables lipopolysaccharide immune receptor activity	TAS Traceable Author Statement more info	PubMed
enables pattern recognition receptor activity	IDA Inferred from Direct Assay more info	PubMed
enables peptidoglycan binding	IDA Inferred from Direct Assay more info	PubMed
enables protein binding	IPI Inferred from Physical Interaction more info	PubMed
enables protein-containing complex binding	IPI Inferred from Physical Interaction more info	PubMed
enables signaling receptor activity	IBA Inferred from Biological aspect of Ancestor more info
enables transmembrane signaling receptor activity	IEA Inferred from Electronic Annotation more info
enables triacyl lipopeptide binding	IBA Inferred from Biological aspect of Ancestor more info
enables triacyl lipopeptide binding	IDA Inferred from Direct Assay more info	PubMed

Process	Evidence Code	Pubs
involved_in I-kappaB phosphorylation	IDA Inferred from Direct Assay more info	PubMed
involved_in apoptotic process	TAS Traceable Author Statement more info	PubMed
involved_in cellular response to bacterial lipopeptide	TAS Traceable Author Statement more info	PubMed
acts_upstream_of_or_within cellular response to diacyl bacterial lipopeptide	IDA Inferred from Direct Assay more info	PubMed
involved_in cellular response to diacyl bacterial lipopeptide	IDA Inferred from Direct Assay more info	PubMed
acts_upstream_of_or_within cellular response to lipoteichoic acid	IDA Inferred from Direct Assay more info	PubMed
involved_in cellular response to lipoteichoic acid	IMP Inferred from Mutant Phenotype more info	PubMed
acts_upstream_of_or_within cellular response to triacyl bacterial lipopeptide	IDA Inferred from Direct Assay more info	PubMed
involved_in cellular response to triacyl bacterial lipopeptide	IDA Inferred from Direct Assay more info	PubMed
involved_in cellular response to type II interferon	IDA Inferred from Direct Assay more info	PubMed
involved_in central nervous system myelin formation	IEA Inferred from Electronic Annotation more info
involved_in defense response to Gram-positive bacterium	IDA Inferred from Direct Assay more info	PubMed
involved_in defense response to virus	IEP Inferred from Expression Pattern more info	PubMed
acts_upstream_of_or_within detection of diacyl bacterial lipopeptide	IDA Inferred from Direct Assay more info	PubMed
acts_upstream_of_or_within detection of triacyl bacterial lipopeptide	IDA Inferred from Direct Assay more info	PubMed
involved_in immune response	TAS Traceable Author Statement more info	PubMed
involved_in inflammatory response	IBA Inferred from Biological aspect of Ancestor more info
involved_in innate immune response	NAS Non-traceable Author Statement more info	PubMed
involved_in innate immune response	TAS Traceable Author Statement more info	PubMed
involved_in learning	ISS Inferred from Sequence or Structural Similarity more info
involved_in leukotriene metabolic process	IEA Inferred from Electronic Annotation more info
involved_in lipopolysaccharide-mediated signaling pathway	IEA Inferred from Electronic Annotation more info
involved_in microglia development	ISS Inferred from Sequence or Structural Similarity more info
involved_in microglial cell activation	IEA Inferred from Electronic Annotation more info
involved_in negative regulation of cell population proliferation	IEA Inferred from Electronic Annotation more info
involved_in negative regulation of phagocytosis	ISS Inferred from Sequence or Structural Similarity more info
involved_in negative regulation of synapse assembly	ISS Inferred from Sequence or Structural Similarity more info
involved_in nitric oxide metabolic process	IEA Inferred from Electronic Annotation more info
acts_upstream_of_or_within positive regulation of NF-kappaB transcription factor activity	IDA Inferred from Direct Assay more info	PubMed
involved_in positive regulation of NF-kappaB transcription factor activity	IDA Inferred from Direct Assay more info	PubMed
involved_in positive regulation of Wnt signaling pathway	IMP Inferred from Mutant Phenotype more info	PubMed
involved_in positive regulation of cellular response to macrophage colony-stimulating factor stimulus	IDA Inferred from Direct Assay more info	PubMed
involved_in positive regulation of chemokine production	IDA Inferred from Direct Assay more info	PubMed
involved_in positive regulation of gene expression	IMP Inferred from Mutant Phenotype more info	PubMed
involved_in positive regulation of inflammatory response	IC Inferred by Curator more info	PubMed
involved_in positive regulation of inflammatory response	IGI Inferred from Genetic Interaction more info	PubMed
involved_in positive regulation of interferon-beta production	ISS Inferred from Sequence or Structural Similarity more info
involved_in positive regulation of interleukin-10 production	IEA Inferred from Electronic Annotation more info
involved_in positive regulation of interleukin-12 production	ISS Inferred from Sequence or Structural Similarity more info
involved_in positive regulation of interleukin-18 production	ISS Inferred from Sequence or Structural Similarity more info
involved_in positive regulation of interleukin-6 production	IDA Inferred from Direct Assay more info	PubMed
involved_in positive regulation of interleukin-6 production	IGI Inferred from Genetic Interaction more info	PubMed
acts_upstream_of positive regulation of interleukin-8 production	IDA Inferred from Direct Assay more info	PubMed
involved_in positive regulation of interleukin-8 production	IDA Inferred from Direct Assay more info	PubMed
involved_in positive regulation of interleukin-8 production	IGI Inferred from Genetic Interaction more info	PubMed
involved_in positive regulation of matrix metallopeptidase secretion	IGI Inferred from Genetic Interaction more info	PubMed
involved_in positive regulation of nitric-oxide synthase biosynthetic process	ISS Inferred from Sequence or Structural Similarity more info
involved_in positive regulation of non-canonical NF-kappaB signal transduction	IDA Inferred from Direct Assay more info	PubMed
involved_in positive regulation of oligodendrocyte differentiation	IEA Inferred from Electronic Annotation more info
involved_in positive regulation of transcription by RNA polymerase II	ISS Inferred from Sequence or Structural Similarity more info
involved_in positive regulation of tumor necrosis factor production	ISS Inferred from Sequence or Structural Similarity more info
involved_in response to fatty acid	IEA Inferred from Electronic Annotation more info
involved_in response to hypoxia	IEA Inferred from Electronic Annotation more info
involved_in response to insulin	IEA Inferred from Electronic Annotation more info
involved_in response to progesterone	IEA Inferred from Electronic Annotation more info
involved_in response to toxic substance	IEA Inferred from Electronic Annotation more info
involved_in signal transduction	TAS Traceable Author Statement more info	PubMed
involved_in toll-like receptor 2 signaling pathway	IDA Inferred from Direct Assay more info	PubMed
involved_in toll-like receptor TLR6:TLR2 signaling pathway	IDA Inferred from Direct Assay more info	PubMed
involved_in toll-like receptor signaling pathway	IBA Inferred from Biological aspect of Ancestor more info
involved_in toll-like receptor signaling pathway	IDA Inferred from Direct Assay more info	PubMed
involved_in toll-like receptor signaling pathway	ISS Inferred from Sequence or Structural Similarity more info

Component	Evidence Code	Pubs
located_in Golgi apparatus	IDA Inferred from Direct Assay more info	PubMed
part_of Toll-like receptor 1-Toll-like receptor 2 protein complex	IDA Inferred from Direct Assay more info	PubMed
part_of Toll-like receptor 1-Toll-like receptor 2 protein complex	IPI Inferred from Physical Interaction more info	PubMed
part_of Toll-like receptor 2-Toll-like receptor 6 protein complex	IPI Inferred from Physical Interaction more info	PubMed
located_in cell body	IEA Inferred from Electronic Annotation more info
located_in cell projection	IEA Inferred from Electronic Annotation more info
located_in cell surface	IDA Inferred from Direct Assay more info	PubMed
located_in cytoplasm	IDA Inferred from Direct Assay more info	PubMed
located_in membrane raft	IDA Inferred from Direct Assay more info	PubMed
located_in phagocytic vesicle membrane	IEA Inferred from Electronic Annotation more info
is_active_in plasma membrane	IBA Inferred from Biological aspect of Ancestor more info
located_in plasma membrane	IDA Inferred from Direct Assay more info	PubMed
located_in plasma membrane	NAS Non-traceable Author Statement more info	PubMed
located_in plasma membrane	TAS Traceable Author Statement more info
part_of receptor complex	IPI Inferred from Physical Interaction more info	PubMed
located_in secretory granule membrane	TAS Traceable Author Statement more info

General protein information

Go to the top of the page Help

Preferred Names: toll-like receptor 2

Names: toll/interleukin-1 receptor-like protein 4

NP_001305716.1

EC 3.2.2.6

NP_001305718.1

EC 3.2.2.6

NP_001305719.1

EC 3.2.2.6

NP_001305720.1

EC 3.2.2.6

NP_001305722.1

EC 3.2.2.6

NP_001305724.1

EC 3.2.2.6

NP_001305725.1

EC 3.2.2.6

NP_003255.2

EC 3.2.2.6

XP_011530517.1

EC 3.2.2.6

XP_011530518.1

EC 3.2.2.6

XP_016864062.1

EC 3.2.2.6

XP_016864064.1

EC 3.2.2.6

XP_047272067.1

EC 3.2.2.6

XP_047272068.1

EC 3.2.2.6

XP_047272069.1

EC 3.2.2.6

XP_047272070.1

EC 3.2.2.6

NCBI Reference Sequences (RefSeq)

Go to the top of the page Help

NEW Try the new Transcript table

RefSeqs maintained independently of Annotated Genomes

These reference sequences exist independently of genome builds. Explain

These reference sequences are curated independently of the genome annotation cycle, so their versions may not match the RefSeq versions in the current genome build. Identify version mismatches by comparing the version of the RefSeq in this section to the one reported in Genomic regions, transcripts, and products above.

Genomic

NG_016229.2 RefSeqGene

Range

5002..26982

Download

GenBank, FASTA, Sequence Viewer (Graphics)

mRNA and Protein(s)

NM_001318787.2 → NP_001305716.1 toll-like receptor 2 precursor

Status: REVIEWED

Description

Transcript Variant: This variant (1) represents the longest transcript. Variants 1-8 all encode the same protein.

Source sequence(s)

AK125659, AW614989, BC033756, BQ017238, CB528396, DA582193

Consensus CDS

CCDS3784.1

UniProtKB/Swiss-Prot

B3Y612, D1CS45, D1CS48, D1CS49, O15454, O60603, Q8NI00

UniProtKB/TrEMBL

A0A0S2Z4S4, B3KWR9

Related

ENSP00000496208.2, ENST00000643501.2

Conserved Domains (6) summary

smart00082
Location:533 → 586

LRRCT; Leucine rich repeat C-terminal domain

smart00255
Location:640 → 784

TIR; Toll - interleukin 1 - resistance

sd00033
Location:54 → 77

LRR_RI; leucine-rich repeat [structural motif]

pfam13855
Location:77 → 135

LRR_8; Leucine rich repeat

cl26018
Location:324 → 558

NEL; C-terminal novel E3 ligase, LRR-interacting

cl26793
Location:40 → 206

PLN00113; leucine-rich repeat receptor-like protein kinase; Provisional
NM_001318789.2 → NP_001305718.1 toll-like receptor 2 precursor

Status: REVIEWED

Description

Transcript Variant: This variant (2) differs in the 5' UTR compared to variant 1. Variants 1-8 all encode the same protein.

Source sequence(s)

AF424051, AK125659, AW614989, BC033756, BQ017238, CB528396

Consensus CDS

CCDS3784.1

UniProtKB/Swiss-Prot

B3Y612, D1CS45, D1CS48, D1CS49, O15454, O60603, Q8NI00

UniProtKB/TrEMBL

A0A0S2Z4S4, B3KWR9

Related

ENSP00000494425.1, ENST00000642700.2

Conserved Domains (6) summary

smart00082
Location:533 → 586

LRRCT; Leucine rich repeat C-terminal domain

smart00255
Location:640 → 784

TIR; Toll - interleukin 1 - resistance

sd00033
Location:54 → 77

LRR_RI; leucine-rich repeat [structural motif]

pfam13855
Location:77 → 135

LRR_8; Leucine rich repeat

cl26018
Location:324 → 558

NEL; C-terminal novel E3 ligase, LRR-interacting

cl26793
Location:40 → 206

PLN00113; leucine-rich repeat receptor-like protein kinase; Provisional
NM_001318790.2 → NP_001305719.1 toll-like receptor 2 precursor

Status: REVIEWED

Description

Transcript Variant: This variant (4) differs in the 5' UTR compared to variant 1. Variants 1-8 all encode the same protein.

Source sequence(s)

AF424051, AK125659, AW614989, BC033756, BQ017238, CB528396, DA870971

Consensus CDS

CCDS3784.1

UniProtKB/Swiss-Prot

B3Y612, D1CS45, D1CS48, D1CS49, O15454, O60603, Q8NI00

UniProtKB/TrEMBL

A0A0S2Z4S4, B3KWR9

Conserved Domains (6) summary

smart00082
Location:533 → 586

LRRCT; Leucine rich repeat C-terminal domain

smart00255
Location:640 → 784

TIR; Toll - interleukin 1 - resistance

sd00033
Location:54 → 77

LRR_RI; leucine-rich repeat [structural motif]

pfam13855
Location:77 → 135

LRR_8; Leucine rich repeat

cl26018
Location:324 → 558

NEL; C-terminal novel E3 ligase, LRR-interacting

cl26793
Location:40 → 206

PLN00113; leucine-rich repeat receptor-like protein kinase; Provisional
NM_001318791.2 → NP_001305720.1 toll-like receptor 2 precursor

Status: REVIEWED

Description

Transcript Variant: This variant (5) differs in the 5' UTR compared to variant 1. Variants 1-8 all encode the same protein.

Source sequence(s)

AF424052, AK125659, AW614989, BC033756, BQ017238, CB528396

Consensus CDS

CCDS3784.1

UniProtKB/Swiss-Prot

B3Y612, D1CS45, D1CS48, D1CS49, O15454, O60603, Q8NI00

UniProtKB/TrEMBL

A0A0S2Z4S4, B3KWR9

Conserved Domains (6) summary

smart00082
Location:533 → 586

LRRCT; Leucine rich repeat C-terminal domain

smart00255
Location:640 → 784

TIR; Toll - interleukin 1 - resistance

sd00033
Location:54 → 77

LRR_RI; leucine-rich repeat [structural motif]

pfam13855
Location:77 → 135

LRR_8; Leucine rich repeat

cl26018
Location:324 → 558

NEL; C-terminal novel E3 ligase, LRR-interacting

cl26793
Location:40 → 206

PLN00113; leucine-rich repeat receptor-like protein kinase; Provisional
NM_001318793.2 → NP_001305722.1 toll-like receptor 2 precursor

Status: REVIEWED

Description

Transcript Variant: This variant (6) differs in the 5' UTR compared to variant 1. Variants 1-8 all encode the same protein.

Source sequence(s)

AF424051, AK125659, AW614989, BC033756, BQ017238, CB528396, DA460298

Consensus CDS

CCDS3784.1

UniProtKB/Swiss-Prot

B3Y612, D1CS45, D1CS48, D1CS49, O15454, O60603, Q8NI00

UniProtKB/TrEMBL

A0A0S2Z4S4, B3KWR9

Conserved Domains (6) summary

smart00082
Location:533 → 586

LRRCT; Leucine rich repeat C-terminal domain

smart00255
Location:640 → 784

TIR; Toll - interleukin 1 - resistance

sd00033
Location:54 → 77

LRR_RI; leucine-rich repeat [structural motif]

pfam13855
Location:77 → 135

LRR_8; Leucine rich repeat

cl26018
Location:324 → 558

NEL; C-terminal novel E3 ligase, LRR-interacting

cl26793
Location:40 → 206

PLN00113; leucine-rich repeat receptor-like protein kinase; Provisional
NM_001318795.2 → NP_001305724.1 toll-like receptor 2 precursor

Status: REVIEWED

Description

Transcript Variant: This variant (7) differs in the 5' UTR compared to variant 1. Variants 1-8 all encode the same protein.

Source sequence(s)

AF424053, AK125659, AW614989, BC033756, BQ017238, CB528396

Consensus CDS

CCDS3784.1

UniProtKB/Swiss-Prot

B3Y612, D1CS45, D1CS48, D1CS49, O15454, O60603, Q8NI00

UniProtKB/TrEMBL

A0A0S2Z4S4, B3KWR9

Conserved Domains (6) summary

smart00082
Location:533 → 586

LRRCT; Leucine rich repeat C-terminal domain

smart00255
Location:640 → 784

TIR; Toll - interleukin 1 - resistance

sd00033
Location:54 → 77

LRR_RI; leucine-rich repeat [structural motif]

pfam13855
Location:77 → 135

LRR_8; Leucine rich repeat

cl26018
Location:324 → 558

NEL; C-terminal novel E3 ligase, LRR-interacting

cl26793
Location:40 → 206

PLN00113; leucine-rich repeat receptor-like protein kinase; Provisional
NM_001318796.2 → NP_001305725.1 toll-like receptor 2 precursor

Status: REVIEWED

Description

Transcript Variant: This variant (8) differs in the 5' UTR compared to variant 1. Variants 1-8 all encode the same protein.

Source sequence(s)

AF424049, AK125659, AW614989, BC033756, BQ017238, CB528396

Consensus CDS

CCDS3784.1

UniProtKB/Swiss-Prot

B3Y612, D1CS45, D1CS48, D1CS49, O15454, O60603, Q8NI00

UniProtKB/TrEMBL

A0A0S2Z4S4, B3KWR9

Related

ENSP00000495339.1, ENST00000642580.1

Conserved Domains (6) summary

smart00082
Location:533 → 586

LRRCT; Leucine rich repeat C-terminal domain

smart00255
Location:640 → 784

TIR; Toll - interleukin 1 - resistance

sd00033
Location:54 → 77

LRR_RI; leucine-rich repeat [structural motif]

pfam13855
Location:77 → 135

LRR_8; Leucine rich repeat

cl26018
Location:324 → 558

NEL; C-terminal novel E3 ligase, LRR-interacting

cl26793
Location:40 → 206

PLN00113; leucine-rich repeat receptor-like protein kinase; Provisional
NM_003264.5 → NP_003255.2 toll-like receptor 2 precursor

See identical proteins and their annotated locations for NP_003255.2

Status: REVIEWED

Description

Transcript Variant: This variant (3) differs in the 5' UTR compared to variant 1. Variants 1-8 all encode the same protein.

Source sequence(s)

AF424049, AI493140, AW614989, BC033756, BQ017238, DQ012267

Consensus CDS

CCDS3784.1

UniProtKB/Swiss-Prot

B3Y612, D1CS45, D1CS48, D1CS49, O15454, O60603, Q8NI00

UniProtKB/TrEMBL

A0A0S2Z4S4, B3KWR9

Related

ENSP00000493968.2, ENST00000646900.2

Conserved Domains (6) summary

smart00082
Location:533 → 586

LRRCT; Leucine rich repeat C-terminal domain

smart00255
Location:640 → 784

TIR; Toll - interleukin 1 - resistance

sd00033
Location:54 → 77

LRR_RI; leucine-rich repeat [structural motif]

pfam13855
Location:77 → 135

LRR_8; Leucine rich repeat

cl26018
Location:324 → 558

NEL; C-terminal novel E3 ligase, LRR-interacting

cl26793
Location:40 → 206

PLN00113; leucine-rich repeat receptor-like protein kinase; Provisional

RefSeqs of Annotated Genomes: GCF_000001405.40-RS_2023_10

The following sections contain reference sequences that belong to a specific genome build. Explain

Reference GRCh38.p14 Primary Assembly

Genomic

NC_000004.12 Reference GRCh38.p14 Primary Assembly

Range

153684280..153710637

Download

GenBank, FASTA, Sequence Viewer (Graphics)

mRNA and Protein(s)

XM_047416111.1 → XP_047272067.1 toll-like receptor 2 isoform X1

UniProtKB/Swiss-Prot

B3Y612, D1CS45, D1CS48, D1CS49, O15454, O60603, Q8NI00

UniProtKB/TrEMBL

A0A0S2Z4S4
XM_047416113.1 → XP_047272069.1 toll-like receptor 2 isoform X1

UniProtKB/Swiss-Prot

B3Y612, D1CS45, D1CS48, D1CS49, O15454, O60603, Q8NI00

UniProtKB/TrEMBL

A0A0S2Z4S4
XM_017008573.2 → XP_016864062.1 toll-like receptor 2 isoform X1

UniProtKB/Swiss-Prot

B3Y612, D1CS45, D1CS48, D1CS49, O15454, O60603, Q8NI00

UniProtKB/TrEMBL

A0A0S2Z4S4, B3KWR9

Related

ENSP00000496676.2, ENST00000646219.2

Conserved Domains (6) summary

smart00082
Location:533 → 586

LRRCT; Leucine rich repeat C-terminal domain

smart00255
Location:640 → 784

TIR; Toll - interleukin 1 - resistance

sd00033
Location:54 → 77

LRR_RI; leucine-rich repeat [structural motif]

pfam13855
Location:77 → 135

LRR_8; Leucine rich repeat

cl26018
Location:324 → 558

NEL; C-terminal novel E3 ligase, LRR-interacting

cl26793
Location:40 → 206

PLN00113; leucine-rich repeat receptor-like protein kinase; Provisional
XM_047416112.1 → XP_047272068.1 toll-like receptor 2 isoform X1

UniProtKB/Swiss-Prot

B3Y612, D1CS45, D1CS48, D1CS49, O15454, O60603, Q8NI00

UniProtKB/TrEMBL

A0A0S2Z4S4
XM_017008575.2 → XP_016864064.1 toll-like receptor 2 isoform X1

UniProtKB/Swiss-Prot

B3Y612, D1CS45, D1CS48, D1CS49, O15454, O60603, Q8NI00

UniProtKB/TrEMBL

A0A0S2Z4S4, B3KWR9

Conserved Domains (6) summary

smart00082
Location:533 → 586

LRRCT; Leucine rich repeat C-terminal domain

smart00255
Location:640 → 784

TIR; Toll - interleukin 1 - resistance

sd00033
Location:54 → 77

LRR_RI; leucine-rich repeat [structural motif]

pfam13855
Location:77 → 135

LRR_8; Leucine rich repeat

cl26018
Location:324 → 558

NEL; C-terminal novel E3 ligase, LRR-interacting

cl26793
Location:40 → 206

PLN00113; leucine-rich repeat receptor-like protein kinase; Provisional
XM_011532215.3 → XP_011530517.1 toll-like receptor 2 isoform X1

See identical proteins and their annotated locations for XP_011530517.1

UniProtKB/Swiss-Prot

B3Y612, D1CS45, D1CS48, D1CS49, O15454, O60603, Q8NI00

UniProtKB/TrEMBL

A0A0S2Z4S4, B3KWR9

Conserved Domains (6) summary

smart00082
Location:533 → 586

LRRCT; Leucine rich repeat C-terminal domain

smart00255
Location:640 → 784

TIR; Toll - interleukin 1 - resistance

sd00033
Location:54 → 77

LRR_RI; leucine-rich repeat [structural motif]

pfam13855
Location:77 → 135

LRR_8; Leucine rich repeat

cl26018
Location:324 → 558

NEL; C-terminal novel E3 ligase, LRR-interacting

cl26793
Location:40 → 206

PLN00113; leucine-rich repeat receptor-like protein kinase; Provisional
XM_011532216.3 → XP_011530518.1 toll-like receptor 2 isoform X1

See identical proteins and their annotated locations for XP_011530518.1

UniProtKB/Swiss-Prot

B3Y612, D1CS45, D1CS48, D1CS49, O15454, O60603, Q8NI00

UniProtKB/TrEMBL

A0A0S2Z4S4, B3KWR9

Conserved Domains (6) summary

smart00082
Location:533 → 586

LRRCT; Leucine rich repeat C-terminal domain

smart00255
Location:640 → 784

TIR; Toll - interleukin 1 - resistance

sd00033
Location:54 → 77

LRR_RI; leucine-rich repeat [structural motif]

pfam13855
Location:77 → 135

LRR_8; Leucine rich repeat

cl26018
Location:324 → 558

NEL; C-terminal novel E3 ligase, LRR-interacting

cl26793
Location:40 → 206

PLN00113; leucine-rich repeat receptor-like protein kinase; Provisional
XM_047416114.1 → XP_047272070.1 toll-like receptor 2 isoform X1

UniProtKB/Swiss-Prot

B3Y612, D1CS45, D1CS48, D1CS49, O15454, O60603, Q8NI00

UniProtKB/TrEMBL

A0A0S2Z4S4